Related references
Note: Only part of the references are listed.Inhibitory activity of reuterin, nisin, lysozyme and nitrite against vegetative cells and spores of dairy-related Clostridium species
Marta Avila et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2014)
Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis
Claudia Slimings et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
Christina M. Surawicz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Analysis of Anti-Clostridium difficile Activity of Thuricin CD, Vancomycin, Metronidazole, Ramoplanin, and Actagardine, both Singly and in Paired Combinations
Harsh Mathur et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Anti-infective properties of bacteriocins: an update
Riadh Hammami et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Clostridium difficile infection
J. Daniel Stanley et al.
CURRENT PROBLEMS IN SURGERY (2013)
Isolation and characterization of bacteriocin-producing bacteria from the intestinal microbiota of elderly Irish subjects
B. Lakshminarayanan et al.
JOURNAL OF APPLIED MICROBIOLOGY (2013)
Activate to Eradicate: Inhibition of Clostridium difficile Spore Outgrowth by the Synergistic Effects of Osmotic Activation and Nisin
Michelle M. Nerandzic et al.
PLOS ONE (2013)
Mechanism of Inhibition of Bacillus anthracis Spore Outgrowth by the Lantibiotic Nisin
Ian M. Gut et al.
ACS CHEMICAL BIOLOGY (2011)
Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
Vanessa Stevens et al.
CLINICAL INFECTIOUS DISEASES (2011)
Control of late blowing in cheese by adding lacticin 3147-producing Lactococcus lactis IFPL 3593 to the starter
M. Carmen Martinez-Cuesta et al.
INTERNATIONAL DAIRY JOURNAL (2010)
A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin
Gerald W. Tannock et al.
MICROBIOLOGY-SGM (2010)
Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile
Mary C. Rea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V
Des Field et al.
MICROBIAL BIOTECHNOLOGY (2010)
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Maja Rupnik et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Inhibition of Bacillus anthracis Spore Outgrowth by Nisin
Ian M. Gut et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Emergence of reduced susceptibility to metronidazole in Clostridium difficile
Simon D. Baines et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Nisin Z inhibits the growth of Candida albicans and its transition from blastospore to hyphal form
C. Le Lay et al.
JOURNAL OF APPLIED MICROBIOLOGY (2008)
Bile salts and glycine as cogerminants for Clostridium difficile spores
Joseph A. Sorg et al.
JOURNAL OF BACTERIOLOGY (2008)
Metronidazole resistance in Clostridium difficile is heterogeneous
T. Pelaez et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficile-associated disease (CDAD)
Daniel Paredes-Sabja et al.
MICROBIOLOGY-SGM (2008)
Clostridium difficile— More Difficult Than Ever
Ciarán P. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
In vitro inhibition activity of nisin A, nisin Z, pediocin PA-1 and antibiotics against common intestinal bacteria
G. Le Blay et al.
LETTERS IN APPLIED MICROBIOLOGY (2007)
Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains
Mary C. Rea et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Molecular characterization and antimicrobial susceptibility patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland
Esvet Mutlu et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Treatment of Clostridium difficile-associated disease: old therapies and new strategies
S Aslam et al.
LANCET INFECTIOUS DISEASES (2005)
In-vitro activity of nisin against clinical isolates of Clostridium difficile
A Bartoloni et al.
JOURNAL OF CHEMOTHERAPY (2004)
Changes in sensitivity patterns to selected antibiotics in Clostridium difficile in geriatric in-patients over an 18-month period
LJ Drummond et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2003)
Inhibition of bacterial growth, enterotoxin production, and spore outgrowth in strains of Bacillus cereus by bacteriocin AS-48
H Abriouel et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2002)
Sensitivities of germinating spores and carvacrol-adapted vegetative cells and spores of Bacillus cereus to nisin and pulsed-electric-field treatment
IE Pol et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity
I Wiedemann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study
J Wistrom et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens
M Mota-Meira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
